B cells in the pre-B-ALL stage have not completed immunoglobulin heavy chain rearrangement (46), and the E2A/PBX1 fusion gene may block B cell differentiation at the pre-B stage by inhibiting the transcriptional activity of E2A (47). Here, PBX1 is linked to acute lymphoblastic leukemia.